
Keywords: حمله ایسکمی گذرا; ACT; activated clotting time; AF; atrial fibrillation; ASAP; Aspirin Plavix Feasibility Study; CAP; Continued Access Protocol; CT; computed tomographic; CV; Cardiovascular; CVD; Cardiovascular disease; DAPT; dual anti-platelet therapy; DAT; device associa